Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization

Anticancer Res. 2017 Oct;37(10):5681-5685. doi: 10.21873/anticanres.12004.

Abstract

Aim: Prospective comparison of cone beam C-Arm CT based parenchymal liver blood volume (PLBV) and dynamic volume perfusion CT (dVPCT) measurements in patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolisation (TACE) with drug-eluting beads (DEB).

Patients and methods: In 16 patients, changes of PLBV and dVPCT measurements [arterial liver parenchyma (ALP); temporal maximum intensity projection (MIP); hepatic perfusion index (HPI); portal venous parenchyma] were correlated to one another and to the modified Response Evaluation Criteria in Solid Tumors (mRECIST).

Results: After TACE, the following parameters showed a statistically significant change (p<0.05) in mean value: PLBV: -4.85 ml/100 ml, ALP: -4.14 ml/100 ml/min, MIP: -0.23 Houndsfield units, HPI: -5.39%, and mRECIST: -20.53 mm. Pre-to-post TACE differences in PLBV showed only weak to very weak correlation to dVPCT parameters (r2<0.24).

Conclusion: Although PLBV and dVPCT parameters showed only a weak to very weak correlation, both methods validly assessed changes in arterial tumor vascularity after DEB TACE.

Keywords: DEB TACE; HCC; PLBV; cone beam CT.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Angiography
  • Blood Flow Velocity
  • Blood Volume
  • Carcinoma, Hepatocellular / blood supply
  • Carcinoma, Hepatocellular / diagnostic imaging*
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / therapy*
  • Chemoembolization, Therapeutic*
  • Cone-Beam Computed Tomography*
  • Humans
  • Liver Circulation*
  • Liver Neoplasms / blood supply
  • Liver Neoplasms / diagnostic imaging*
  • Liver Neoplasms / pathology
  • Liver Neoplasms / therapy*
  • Middle Aged
  • Multidetector Computed Tomography*
  • Perfusion Imaging / methods*
  • Predictive Value of Tests
  • Prospective Studies
  • Regional Blood Flow
  • Reproducibility of Results
  • Time Factors
  • Treatment Outcome